🇺🇸 FDA
Pipeline program

CT-FFR assessment

S2019-025-01

Unknown other completed

Quick answer

CT-FFR assessment for Coronary Artery Disease is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Coronary Artery Disease
Phase
Unknown
Modality
other
Status
completed

Clinical trials